1. Assessment of the Drug Interaction Potential of Ertugliflozin With Sitagliptin, Metformin, Glimepiride, or Simvastatin in Healthy Subjects. Issue 3 (22nd May 2018) Authors: Dawra, Vikas Kumar; Cutler, David L.; Zhou, Susan; Krishna, Rajesh; Shi, Haihong; Liang, Yali; Alvey, Christine; Hickman, Anne; Saur, Didier; Terra, Steven G.; Sahasrabudhe, Vaishali Journal: Clinical pharmacology in drug development Issue: Volume 8:Issue 3(2019) Page Start: 314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bioequivalence of Ertugliflozin/Metformin Fixed‐Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components. Issue 1 (17th June 2019) Authors: Dawra, Vikas Kumar; Liang, Yali; Wei, Hua; Pelletier, Kathleen; Shi, Haihong; Hickman, Anne; Bass, Almasa; Terra, Steven G.; Zhou, Susan; Krishna, Rajesh; Sahasrabudhe, Vaishali Journal: Clinical pharmacology in drug development Issue: Volume 9:Issue 1(2020) Page Start: 50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bioequivalence of Ertugliflozin/Sitagliptin Fixed‐Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components. Issue 7 (20th June 2019) Authors: Fediuk, Daryl J.; Matschke, Kyle; Liang, Yali; Pelletier, Kathleen B.; Wei, Hua; Shi, Haihong; Bass, Almasa; Hickman, Anne; Terra, Steven G.; Zhou, Susan; Krishna, Rajesh; Sahasrabudhe, Vaishali Journal: Clinical pharmacology in drug development Issue: Volume 8:Issue 7(2019) Page Start: 884 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bioequivalence of Metformin in Ertugliflozin/Metformin Fixed‐Dose Combination Tablets to Canadian‐Sourced Metformin Coadministered With Ertugliflozin Under Fasted and Fed States. Issue 5 (2nd November 2020) Authors: Dawra, Vikas Kumar; Pelletier, Kathleen; Matschke, Kyle; Shi, Haihong; Hickman, Anne; Zhou, Susan; Krishna, Rajesh; Sahasrabudhe, Vaishali Journal: Clinical pharmacology in drug development Issue: Volume 10:Issue 5(2021) Page Start: 510 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of Food on the Pharmacokinetics of Ertugliflozin and Its Fixed‐Dose Combinations Ertugliflozin/Sitagliptin and Ertugliflozin/Metformin. Issue 5 (14th November 2018) Authors: Sahasrabudhe, Vaishali; Fediuk, Daryl J.; Matschke, Kyle; Shi, Haihong; Liang, Yali; Hickman, Anne; Bass, Almasa; Terra, Steven G.; Zhou, Susan; Krishna, Rajesh; Dawra, Vikas K. Journal: Clinical pharmacology in drug development Issue: Volume 8:Issue 5(2019) Page Start: 619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. End‐to‐end application of model‐informed drug development for ertugliflozin, a novel sodium‐glucose cotransporter 2 inhibitor. (15th May 2021) Authors: Fediuk, Daryl J.; Nucci, Gianluca; Dawra, Vikas K.; Callegari, Ernesto; Zhou, Susan; Musante, Cynthia J.; Liang, Yali; Sweeney, Kevin; Sahasrabudhe, Vaishali Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 6(2021) Page Start: 529 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Meta‐Analysis of Noncompartmental Pharmacokinetic Parameters of Ertugliflozin to Evaluate Dose Proportionality and UGT1A9 Polymorphism Effect on Exposure. (19th June 2021) Authors: Marshall, Jean‐Claude; Liang, Yali; Sahasrabudhe, Vaishali; Tensfeldt, Thomas; Fediuk, Daryl J.; Zhou, Susan; Krishna, Rajesh; Dawra, Vikas Kumar; Wood, Linda S.; Sweeney, Kevin Journal: Journal of clinical pharmacology Issue: Volume 61:Number 9(2021) Page Start: 1220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Novel Application of the Two‐Period Microtracer Approach to Determine Absolute Oral Bioavailability and Fraction Absorbed of Ertugliflozin. Issue 4 (25th March 2018) Authors: Raje, Sangeeta; Callegari, Ernesto; Sahasrabudhe, Vaishali; Vaz, Alfin; Shi, Haihong; Fluhler, Eric; Woolf, Eric J.; Schildknegt, Klaas; Matschke, Kyle; Alvey, Christine; Zhou, Susan; Papadopoulos, Dimitris; Fountaine, Robert; Saur, Didier; Terra, Steven G.; Stevens, Lloyd; Gaunt, Daniel; Cutler,... Journal: Clinical and translational science Issue: Volume 11:Issue 4(2018) Page Start: 405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Population Pharmacokinetic Analyses of Ertugliflozin in Select Ethnic Populations. Issue 11 (2nd July 2021) Authors: Fediuk, Daryl J.; Sahasrabudhe, Vaishali; Dawra, Vikas Kumar; Zhou, Susan; Sweeney, Kevin Journal: Clinical pharmacology in drug development Issue: Volume 10:Issue 11(2021) Page Start: 1297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Population Pharmacokinetic Model for Ertugliflozin in Healthy Subjects and Patients With Type 2 Diabetes Mellitus. Issue 7 (17th November 2020) Authors: Fediuk, Daryl J.; Zhou, Susan; Dawra, Vikas Kumar; Sahasrabudhe, Vaishali; Sweeney, Kevin Journal: Clinical pharmacology in drug development Issue: Volume 10:Issue 7(2021) Page Start: 696 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗